Volition Presents New Liquid Biopsy Method for Early-Stage Cancer
VolitionRx detailed a new liquid biopsy cancer-detection method at the annual congress of the European Society for Medical Oncology.
Read MorePosted by Andy Lundin | Oct 23, 2023 | Cancer, Molecular Diagnostics |
VolitionRx detailed a new liquid biopsy cancer-detection method at the annual congress of the European Society for Medical Oncology.
Read MorePosted by Andy Lundin | Oct 19, 2023 | Lung Cancer |
Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients.
Read MorePosted by Andy Lundin | Oct 18, 2023 | Cancer |
The University of Illinois Chicago will participate in a study of a test that screens for a shared cancer signal in patient blood samples.
Read MorePosted by Andy Lundin | Oct 17, 2023 | Dementias & Alzheimer’s |
PharmaKure announced successful study results for a novel whole-blood test for quantifying Alzheimer’s Disease biomarkers.
Read MorePosted by Chris Wolski | Oct 13, 2023 | Breast |
Invitae announced the results of its study on universal hereditary cancer genetic testing in breast cancer patients in a rural population.
Read More